These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1004 related articles for article (PubMed ID: 35082777)

  • 1. Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection.
    Patterson BK; Francisco EB; Yogendra R; Long E; Pise A; Rodrigues H; Hall E; Herrera M; Parikh P; Guevara-Coto J; Triche TJ; Scott P; Hekmati S; Maglinte D; Chang X; Mora-Rodríguez RA; Mora J
    Front Immunol; 2021; 12():746021. PubMed ID: 35082777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning.
    Patterson BK; Guevara-Coto J; Yogendra R; Francisco EB; Long E; Pise A; Rodrigues H; Parikh P; Mora J; Mora-Rodríguez RA
    Front Immunol; 2021; 12():700782. PubMed ID: 34262570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated circulating monocytes and monocyte activation in COVID-19 convalescent individuals.
    Park J; Dean LS; Jiyarom B; Gangcuangco LM; Shah P; Awamura T; Ching LL; Nerurkar VR; Chow DC; Igno F; Shikuma CM; Devendra G
    Front Immunol; 2023; 14():1151780. PubMed ID: 37077911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-cell RNA sequencing reveals characteristics of myeloid cells in post-acute sequelae of SARS-CoV-2 patients with persistent respiratory symptoms.
    Yoon H; Dean LS; Jiyarom B; Khadka VS; Deng Y; Nerurkar VR; Chow DC; Shikuma CM; Devendra G; Koh Y; Park J
    Front Immunol; 2023; 14():1268510. PubMed ID: 38259488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.
    LaVergne SM; Stromberg S; Baxter BA; Webb TL; Dutt TS; Berry K; Tipton M; Haberman J; Massey BR; McFann K; Alnachoukati O; Zier L; Heacock T; Ebel GD; Henao-Tamayo M; Dunn J; Ryan EP
    BMC Infect Dis; 2021 Jul; 21(1):677. PubMed ID: 34256735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral immunity to an endemic coronavirus is associated with postacute sequelae of COVID-19 in individuals with rheumatic diseases.
    Herman JD; Atyeo C; Zur Y; Cook CE; Patel NJ; Vanni KM; Kowalski EN; Qian G; Srivatsan S; Shadick NA; Rao DA; Kellman B; Mann CJ; Lauffenburger D; Wallace ZS; Sparks JA; Alter G
    Sci Transl Med; 2023 Sep; 15(712):eadf6598. PubMed ID: 37672567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of Post-Acute-Sequelae of COVID-19 by Cargo Protein Biomarkers of Blood Total Extracellular Vesicles in Acute COVID-19.
    Goetzl EJ; Yao PJ; Kapogiannis D
    Am J Med; 2023 Aug; 136(8):824-829. PubMed ID: 37072092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects.
    Achiron A; Gurevich M; Falb R; Dreyer-Alster S; Sonis P; Mandel M
    Clin Microbiol Infect; 2021 Sep; 27(9):1349.e1-1349.e6. PubMed ID: 33975009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive Immune Profiling Reveals CD56
    Dutt TS; LaVergne SM; Webb TL; Baxter BA; Stromberg S; McFann K; Berry K; Tipton M; Alnachoukati O; Zier L; Ebel G; Dunn J; Henao-Tamayo M; Ryan EP
    J Immunol; 2022 Feb; 208(3):685-696. PubMed ID: 34987111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquid biomarkers of macrophage dysregulation and circulating spike protein illustrate the biological heterogeneity in patients with post-acute sequelae of COVID-19.
    Schultheiß C; Willscher E; Paschold L; Gottschick C; Klee B; Bosurgi L; Dutzmann J; Sedding D; Frese T; Girndt M; Höll JI; Gekle M; Mikolajczyk R; Binder M
    J Med Virol; 2023 Jan; 95(1):e28364. PubMed ID: 36458566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection.
    Moghimi N; Di Napoli M; Biller J; Siegler JE; Shekhar R; McCullough LD; Harkins MS; Hong E; Alaouieh DA; Mansueto G; Divani AA
    Curr Neurol Neurosci Rep; 2021 Jun; 21(9):44. PubMed ID: 34181102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent circulation of soluble and extracellular vesicle-linked Spike protein in individuals with postacute sequelae of COVID-19.
    Craddock V; Mahajan A; Spikes L; Krishnamachary B; Ram AK; Kumar A; Chen L; Chalise P; Dhillon NK
    J Med Virol; 2023 Feb; 95(2):e28568. PubMed ID: 36756925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duration of post-COVID-19 symptoms is associated with sustained SARS-CoV-2-specific immune responses.
    Files JK; Sarkar S; Fram TR; Boppana S; Sterrett S; Qin K; Bansal A; Long DM; Sabbaj S; Kobie JJ; Goepfert PA; Erdmann N
    JCI Insight; 2021 Aug; 6(15):. PubMed ID: 34143754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating viral and autoimmune T cell responses associated with post-acute sequelae of COVID-19.
    Williams GP; Yu ED; Shapiro K; Wang E; Freuchet A; Frazier A; Lindestam Arlehamn CS; Sette A; da Silva Antunes R
    Hum Immunol; 2024 May; 85(3):110770. PubMed ID: 38433036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurological post-acute sequelae of SARS-CoV-2 infection.
    Takao M; Ohira M
    Psychiatry Clin Neurosci; 2023 Feb; 77(2):72-83. PubMed ID: 36148558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other Immunoassays.
    Semmler G; Traugott MT; Graninger M; Hoepler W; Seitz T; Kelani H; Karolyi M; Pawelka E; Aragón de La Cruz S; Puchhammer-Stöckl E; Aberle SW; Stiasny K; Zoufaly A; Aberle JH; Weseslindtner L
    J Clin Microbiol; 2021 Apr; 59(5):. PubMed ID: 33602698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Numbers and phenotype of non-classical CD14dimCD16+ monocytes are predictors of adverse clinical outcome in patients with coronary artery disease and severe SARS-CoV-2 infection.
    Mueller KAL; Langnau C; Günter M; Pöschel S; Gekeler S; Petersen-Uribe Á; Kreisselmeier KP; Klingel K; Bösmüller H; Li B; Jaeger P; Castor T; Rath D; Gawaz MP; Autenrieth SE
    Cardiovasc Res; 2021 Jan; 117(1):224-239. PubMed ID: 33188677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent Circulating Severe Acute Respiratory Syndrome Coronavirus 2 Spike Is Associated With Post-acute Coronavirus Disease 2019 Sequelae.
    Swank Z; Senussi Y; Manickas-Hill Z; Yu XG; Li JZ; Alter G; Walt DR
    Clin Infect Dis; 2023 Feb; 76(3):e487-e490. PubMed ID: 36052466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case series: Maraviroc and pravastatin as a therapeutic option to treat long COVID/Post-acute sequelae of COVID (PASC).
    Patterson BK; Yogendra R; Guevara-Coto J; Mora-Rodriguez RA; Osgood E; Bream J; Parikh P; Kreimer M; Jeffers D; Rutland C; Kaplan G; Zgoda M
    Front Med (Lausanne); 2023; 10():1122529. PubMed ID: 36844201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monocytes and Macrophages, Targets of Severe Acute Respiratory Syndrome Coronavirus 2: The Clue for Coronavirus Disease 2019 Immunoparalysis.
    Boumaza A; Gay L; Mezouar S; Bestion E; Diallo AB; Michel M; Desnues B; Raoult D; La Scola B; Halfon P; Vitte J; Olive D; Mege JL
    J Infect Dis; 2021 Aug; 224(3):395-406. PubMed ID: 33493287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.